SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-45.5%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 105.98% |
| 2024 | 51.83% |
| 2023 | -77.26% |
| 2022 | -9.39% |
| 2021 | -185.10% |
| 2020 | 2204.55% |
| 2019 | 0.00% |